Charlottesville, VA - - August 14, 2006 - - openQ, a provider of integrated key relationship management solutions for the life science industry, today announced their KOL Manager V2.5 for life sciences companies in response to the growing complexity of marketing goals for highly valued key opinion leaders. KOL Manager Version 2.5 is currently running live with 10 major pharmaceutical brands.
openQ’s KOL Manager V2.5 offers life sciences companies an unparalleled tool to help with the planning, strategy and tactical execution of the complex process of working with key opinion leaders. Typically, thousands of employees across marketing, sales, clinical groups and medical education departments within large life sciences companies are integrally involved with the KOL program. KOL Manager V2.5 brings added flexibility, through greater use of modularity, lending a level of adaptability to the particular phase of the life cycle of a KOL relationship, through critical phases of developing, marketing and selling that new drug.
Elizabeth Boehm, senior analyst at Forrester Research, writes in her report, The Forrester Wave™: Key Opinion Leader Management Platforms, Q2 2006, “While it is a relative newcomer to the market, openQ has built a very strong technology platform in a short period of time.” Boehm continued, “The company’s dedication to open standards and solid grasp of the broader technical ecosystem into which its system is deployed results in a highly flexible, easy-to-integrate platform that addresses all of the market’s core needs.”
For the life sciences industry focused on optimizing overall marketing processes while meeting compliance standards, KOL management has emerged as a management platform that is also leveraged by compliance officers and CIOs. With a high degree of technical flexibility, easy integration and an open standards structure, KOL Manager V2.5 provides the marketing, planning and analysis capabilities needed to implement a comprehensive KOL management program.
“We have structured the development of KOL Manager to keep pace with the evolution of this business critical management process,” says Jim Zuffoletti, president and co-founder of openQ. “As never before, the industry and market pressures are bearing down on life sciences companies to turn innovation into commercialization. We’ve listened to our customers’ business goals and advanced our solution to map back to managing the complex KOL relationships.”
The openQ KOL Manager V2.5 platform helps address customers’ strategic KOL management needs by relying on goal-oriented information capture and its robust communication features. The openQ application will also facilitate KOL segmentation and profiling that is then accessible across the functional marketing matrix, and throughout a global organization. The openQ KOL Manager platform was configured on the belief that KOL relationships are fundamental to all aspects of the professional marketing process and as such, should be optimized in a seamless and integrated way, saving time by avoiding duplication and multiple systems.
About openQ
openQ, headquartered in Charlottesville, VA, develops and delivers solutions for the strategic management of key relationships across life science and other industries. With a culture committed to improving business insights and intelligence, openQ is focused on the market knowledge and thought leadership that drives technology advances and optimizes business results. For more information, visit www.openq.com.
###
|
|
|
MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 